Next Article in Journal
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC
Next Article in Special Issue
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy
Previous Article in Journal
Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy
 
 
Article

Article Versions Notes

Cancers 2023, 15(13), 3462; https://doi.org/10.3390/cancers15133462
Action Date Notes Link
article xml file uploaded 1 July 2023 10:05 CEST Original file -
article xml uploaded. 1 July 2023 10:05 CEST Update https://www.mdpi.com/2072-6694/15/13/3462/xml
article pdf uploaded. 1 July 2023 10:05 CEST Version of Record https://www.mdpi.com/2072-6694/15/13/3462/pdf
article supplementary file uploaded. 1 July 2023 10:05 CEST - https://www.mdpi.com/2072-6694/15/13/3462#supplementary
article html file updated 1 July 2023 10:07 CEST Original file -
article html file updated 19 July 2023 20:13 CEST Update https://www.mdpi.com/2072-6694/15/13/3462/html
Back to TopTop